You are here

Article Text

Article menu
Download PDFPDF
Miscellaneous
Letter
LGV Chlamydia trachomatis serotypes: an update from Milan, Italy
  1. Susanna Benardon1,
  2. Giovanna Lunghi1,
  3. Patrizia Bono1,
  4. Annarosa Orlandi1,
  5. Francesca Pacela1,
  6. Antonella Zoccoli1,
  7. Enzo Boeri2,
  8. Michela Sampaolo2,
  9. Marco Cusini1
  1. 1 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
  2. 2 San Raffaele Hospital, Milan, Italy
  1. Correspondence to Dr Marco Cusini, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Pace 9, Milan 20122, Italy; m.cusini{at}policlinico.mi.it

http://dx.doi.org/10.1136/sextrans-2016-052985

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Up until 2003, a few cases of Lymphogranuloma venereum (LGV) diagnosed in Europe were known to be caused by L serovars of Chlamydia trachomatis (L1, L2a, L3). However, the current epidemic, which began among European men who have sex with men (MSM) in 2003, has seen the emergence of LGV with novel epidemiological and clinical features (most notably, the variant L2b).

    The evidence reported by this letter from our STI …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.